Trial Information

Summary: A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy. Patients will be allowed to stay on stable doses of current pain medications throughout the study.

Inclusion Criteria:

• has Type 1 or Type 2 diabetes mellitus
• has a history of chronic pain attributable to a symmetrical stocking distribution neuropathy in the lower extremities for a duration of at least six months but less than or equal to five years prior to screening

Exclusion Criteria:

• has neuropathy secondary to non-diabetic causes
• has a significant neurological disorder or a condition that can cause symptoms that mimic peripheral neuropathy or might confound assessment of painful diabetic neuropathy
• has other chronic pain with intensity at or greater than the bilateral pain in the feet/toes
• is using an implanted medical device (eg, spinal cord stimulator, intrathecal pump, or peripheral nerve stimulator) for the treatment of pain
• is pregnant or lactating

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 30, 2008 at 2:37:02 PM